LISTEN TO TLR’S LATEST PODCAST: By Grace Carr Mylan’s EpiPen company has robbed taxpayers roughly $1.27 billion over the last decade, according to a U.S. government report released Wednesday. Republican Sen. Charles Grassley of Iowa posted a copy of the report by the Department of Health and Human Services’ Office, saying that Mylan shortchanged the Medicaid program by classifying EpiPen…
LISTEN TO TLR’S LATEST PODCAST: By Robert Donachie Mylan and Sun Pharmaceuticals face two lawsuits alleging the companies colluded to gouge consumers for a generic pill used to treat asthma and other respiratory problems. A workers union in New York and the Self-Insured Schools of California have filed suit against Mylan and Sun Pharmaceuticals for raising…
LISTEN TO TLR’S LATEST PODCAST: by Micah J. Fleck Mylan’s notoriously rising prices for its EpiPen product as of late has angered economic illiterates who assume this is a result of evil capitalism. But now, CVS Pharmacy is proving said critics wrong by utilizing capitalism itself to provide competition to the EpiPen that does the…
By Micah J. Fleck The news has once again rolled around that the EpiPen, a specific brand of epinephrine auto-injector, has risen in price astronomically – far beyond the normal rate of inflation. Most recently, the company behind the EpiPen, Mylan, has reportedly raised their price from $100 to $500 per pack – right…